U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07428135) titled 'Heart Failure Efficacy and Research Trial (HEART) Platform' on Jan. 15.
Brief Summary: The Heart Failure Efficacy and Research Trial (HEART) Platform is a multicenter, randomized platform study designed to improve outcomes for patients with heart failure through the simultaneous and sequential evaluation of multiple interventions across the spectrum of heart failure.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Heart Failure
Intervention:
OTHER: Domain Intervention(s)
Participants randomized to the experimental arm will receive an intervention being evaluated within an eligible HEART Platform domain at ...